Unveiling the Therapeutic Potential of “Taikong Blue” Lavender Essential Oil and Its Key Compounds in Skin Problems via Network Pharmacology and In Vitro Validation
Journal of Cosmetic Dermatology · 2026
DOI: 10.1111/jocd.70640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2026. Verfasst von Fei Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory of Carbohydrate and Glycoconjugate Drugs, Shandong Freda Pharmaceutical Group co., Ltd., Ji'nan, Shandong, China. Hauptthemen laut MEDLINE: Oils, Volatile, Lavandula, Plant Oils, Skin Diseases. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Shandong Postdoctoral Science Foundation, the Beijing Municipal Education Commission General Project, the Enterprise Technological Innovation Project of Shandong Province.
Abstract (Originalsprache)
Background
Taikong Blue Lavender Essential Oil (TLEO) is derived from a proprietary space‐bred cultivar of Lavandula angustifolia and cultivated under pristine conditions in Xinjiang, China. TLEO has long been used by regional people to treat various skin disorders such as hyperpigmentation, trans‐epidermal water loss, collagen degradation, and poor wound healing. Despite the ethnopharmacological applications of TLEO, the molecular basis of its dermatological efficacy remains poorly defined.
Method
This study integrated network pharmacology, molecular docking, and in vitro assays to systematically investigate how TLEO works against inflammatory skin conditions, focusing on its key compounds and biological targets.
Results
A total of 66 skin disorder‐related genes were identified through network pharmacology, with gene enrichment analyses highlighting the TNF signaling pathway as a critical mediator. Protein–protein interaction analysis revealed MMP9, EGFR, and PTGS2 as core targets. Molecular docking confirmed that linalool and linalyl acetate, the primary constituents of TLEO, exhibited moderate binding affinities with these targets. In vitro experiments using TNF‐ α ‐stimulated HaCaT cells demonstrated that treatment with 0.01% TLEO significantly ( p < 0.05) reduced oxidative stress markers (NO, ROS, MDA), restored antioxidant enzymes (SOD, CAT), and downregulated inflammatory cytokines (IL‐6, IL‐1 β , IL‐8). TLEO also inhibited the phosphorylation of p38 MAPK and NF‐ κ B p65, suppressed PTGS2 and MMP9 expression, and restored EGFR levels, indicating anti‐inflammatory and barrier‐restorative functions.
Conclusions
The study establishes a scientific foundation for the use of TLEO as a multifunctional ingredient in dermatological applications and highlights its value as a sustainable crop for regional economic development in Xinjiang.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Key Laboratory of Carbohydrate and Glycoconjugate Drugs, Shandong Freda Pharmaceutical Group co., Ltd., Ji'nan, Shandong, China.
- Department of Natural Product Chemistry, Key Laboratory of Natural Products & Chemical Biology of Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Ji'nan, China.
- Beijing Technology and Business University, Beijing, China.
ORCID-Profile: Yingyu Zhang, Hua Wu
Förderung
- the Shandong Postdoctoral Science Foundation
- the Beijing Municipal Education Commission General Project
- the Enterprise Technological Innovation Project of Shandong Province
Zitieren
APA
Liu, F., Zhang, Y., Abedin, M., Song, J., Yang, S., Lou, H., Dou, X., Xiao, J., & Wu, H. (2026). Unveiling the Therapeutic Potential of “Taikong Blue” Lavender Essential Oil and Its Key Compounds in Skin Problems via Network Pharmacology and In Vitro Validation. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70640
Vancouver
Liu F, Zhang Y, Abedin M, Song J, Yang S, Lou H, et al. Unveiling the Therapeutic Potential of “Taikong Blue” Lavender Essential Oil and Its Key Compounds in Skin Problems via Network Pharmacology and In Vitro Validation. Journal of Cosmetic Dermatology. 2026. doi:10.1111/jocd.70640
BibTeX
@article{Liu2026,
author = {Liu, Fei and Zhang, Yingyu and Abedin, Minhazul and Song, Jingyi and Yang, Suzhen and Lou, Hongxiang and Dou, Xixi and Xiao, Junsong and Wu, Hua},
title = {Unveiling the Therapeutic Potential of “Taikong Blue” Lavender Essential Oil and Its Key Compounds in Skin Problems via Network Pharmacology and In Vitro Validation},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
doi = {10.1111/jocd.70640}
}
EUVIMED